Correlates of obesity in postmenopausal women with breast cancer: Comparison of genetic, demographic, disease-related, life history and dietary factors

International Journal of Obesity

Volumn 28, Issue 1, 2004, Pages 49-56

  Wasserman, L ^a,b   Flatt, S W ^b   Natarajan, L ^b   Laughlin, G ^c   Matusalem, M ^b   Faerber, S ^b   Rock, C L ^b,c   Barrett Connor, E ^b,c   Pierce, J P ^b,c  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

AIB1; Body mass index; Menarche; Postmenopausal breast cancer; PROGINS; Prognosis

Indexed keywords

POLYGLUTAMINE; PROGESTERONE RECEPTOR; STEROID RECEPTOR COACTIVATOR 1; STEROID RECEPTOR COACTIVATOR 3; TRANSCRIPTION FACTOR;

ADJUVANT THERAPY; ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; BREAST CANCER; BREAST TUMOR; CALORIC INTAKE; CANCER STAGING; COMPARATIVE STUDY; DEMOGRAPHY; DENATURATION; DIET; DIETARY INTAKE; DNA SEQUENCE; EXERCISE; FAMILY HISTORY; FEMALE; GEL ELECTROPHORESIS; GENE IDENTIFICATION; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; HEREDITY; HUMAN; LIFE HISTORY; LIFESTYLE; MAJOR CLINICAL STUDY; MEDICAL RECORD; MENARCHE; MENSTRUAL CYCLE; OBESITY; PHYSIOLOGY; POLYMERASE CHAIN REACTION; POSTMENOPAUSE; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; REGRESSION ANALYSIS; REPRODUCTIVE HEALTH; RISK FACTOR; SMOKING HABIT;

ADULT; AGED; BODY MASS INDEX; BREAST NEOPLASMS; CROSS-SECTIONAL STUDIES; DIET; ENERGY INTAKE; FEMALE; GENOTYPE; HUMANS; LIFE STYLE; MENARCHE; MIDDLE AGED; OBESITY; POLYMORPHISM, GENETIC; POSTMENOPAUSE; RECEPTORS, PROGESTERONE; REGRESSION ANALYSIS; RISK FACTORS; TRANSCRIPTION FACTORS;

EID: 0942279551     PISSN: 03070565     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijo.0802481     Document Type: Article

References (43)

1. Laitinen J, Power C, Järvelin M-R. Family social class, maternal body mass index, childhood body mass index and age at menarche as predictors of adult obesity. Am J Clin Nutr 2001; 74: 287-294.
2. Friedenreich CM. Review of anthropometric factors and breast cancer risk. Eur J Can Prev 2001; 10: 15-32.
3. Stoll BA. Adiposity as a risk determinant for postmenopausal breast cancer. Int J Obesity 2000; 24: 527-533.
4. Goodwin PJ, Boyd NR. Body size and breast cancer prognosis: a critical review of the evidence. Br Can Res Treat 1990; 16: 205-214.
5. Kumar NB, Cantor A, Allen K, Cox CE. Android obesity at diagnosis and breast carcinoma survival. Cancer 2000; 88: 2751-2757.
6. Rock CL, Demark-Wahnefried W. Nutrition and survival after the diagnosis of breast cancer: a review of the evidence. J Clin Oncol 2002; 20: 3302-3316.
7. Wood TL, Yee D. IGFs and IGFBPs in the normal mammary gland and in breast cancer. J Mamm Gland Biol Neoplasia 2000; 5: 1-5.
8. Hankinson SE, Willett WC, Manson JE, Colditz GA, Hunger DJ, Spiegelman D, Barbieri RL, Speizer FE. Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women. J Natl Cancer Inst 1998; 90: 1292-1299.
9. Rammuni M, Ramunni J, Oleandri S, Procopio M. Relationships between IGF-1 and age, gender, body mass, fat distribution, metabolic and hormonal variables in obese patients. Int J Obes Relat Metab Disord 1999; 23: 612-618.
10. Stoll BA. Biological mechanisms in breast cancer invasiveness: relevance to preventive interventions. Eur J Can Prev 2000; 9: 73-79.
11. Newman SC, Lees AW, Jenkins HJ. The effect of body mass index and oestrogen receptor level on survival of breast cancer patients. Int J Epidemiol 1997; 26: 484-490.
12. Pollak, M. Insulin-like growth factor physiology and cancer risk. Eur J Cancer 2000; 36: 1224-1228.
13. Yee D, Lee AV. Crosstalk between the insulin-like growth factors and estrogens in breast cancer. J Mamm Gland Biol Neoplasia 2000; 5: 107-115.
14. Surmacz E. Function of the IGF-1 receptor in breast cancer. J Mamm Gland Biol Neoplasia 2000; 5: 95-105.
15. Vermeulen A, Deslypere JP, Paridens R, Leclercq G, Roy F, Heuson JC. Aromatase, 17-beta-hydroxylase dehydrogenase and intratissular sex hormone concentrations in cancerous and normal glandular breast tissue in postmenopausal women. Eur J Cancer Clin Oncol 1986; 22: 515-525.
16. Vassen L, Deslypere JP, Paridaens R, Leclercq G, Roy F, Heuson JC. Human insulin receptor substrate-2 (IRS-2) is a primary progesterone response gene. Mol Endocrinol 1999; 13: 485-494.
17. Wang Z, Rose DW, Hermanson O, Liu R, Herman T, Wu W, Daniel D, Gleiberman A, Krones A, Pratt K, Rosenfeld R, Glass CK. Regulation of somatic growth by the p160 coactivator p/CIP. Proc Natl Acad Sci USA 2000; 97: 13549-13554.
18. McDonnell DP, Norris JD. Connections and regulation of the human estrogen receptor. Science 2002; 296: 1642-1644.
19. Aranda A, Pascual A. Nuclear hormone receptors and gene expression. Physiol Rev 2001; 81: 269-1304.
20. Mulac-Jericevic B, Mullinax RA, DeMayo FJ, Lydon JP, Conneely OM. Subgroup of reproductive functions of progesterone mediated by progesterone-B isoform. Science 2000; 289: 1751-1754.
21. Maccario M, DeMayo FJ, Lydon J, Conneely OM. The GH/IGF-1 axis in obesity: influence of neuro-endocrine and metabolic factors. Int J Obes 2000; 24: S96-S99.
22. Anzick SL, Kononen J, Walker RL, Azorsa DO, Tanner MM, Guan X-Y, Sauter G, Kallioniemi O-P, Trent JM, Meltzer PS. AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science 1997; 277: 965-968.
23. Xu J, Liao L, Ning G, Yoshida-Komiya H, Deng C, O'Malley B. The steroid receptor coactivator SRC-3 (p/CIP/RAC3/AIB1/ACTR/ TRAM-1) is required for normal growth, puberty, female reproductive function, and mammary gland development. Proc Natl Acad Sci USA 2000; 97: 6379-6384.
24. Wang-Gohrke S, Chang-Claude J, Becher H, Kieback DG, Runnebaum IB. Progesterone receptor gene polymorphism is associated with decreased risk for breast cancer by age 50. Cancer Res 2000; 60: 2348-2350.
25. Rowe SM, Coughlan SJ, McKenna NJ, Garrett E, Kieback DG, Carney DN, Headon DR. Ovarian carcinoma-associated TaqI restriction fragment length polymorphism in intron G of the progesterone receptor gene is due to an Alu sequence insertion. Cancer Res 1995; 55: 2743-2745.
26. Manolitsas TP, Englefield P, Eccles DM, Campbell IG. No association of a 306 bp insertion polymorphism in the progesterone receptor gene with ovarian and breast cancer. Br J Cancer 1997; 75: 1397-1399.
27. Lancaster JM, Berchuck A, Carney ME, Wiseman R, Taylor JA. Progesterone receptor gene polymorphism and risk for breast and ovarian cancer. Br J Cancer 1998; 78: 277-278.
28. Donaldson CJ, Crapanzano JP, Watson JC, Levine EA, Batzer MA. PROGINS Alu insertion and human genomic diversity. Mutat Res 2002; 501: 137-141.
29. Kieback DG, Tong X-W, Weigel NL, Agoulnik IU. A genetic mutation in the progesterone receptor (PROGINS) leads to an increased risk of non-familial breast and ovarian cancer causing inadequate control of estrogen receptor driven proliferation. J Soc Gynecol Invest 1998; 5: A40.
30. Runnebaum IB, Wang-Gohrke S, Vesprini D, Kreienberg R, Lynch H, Moslehi R, Ghadirian P, Weber B, Godwin AK, Risch H, Garber J, Lerman C, Olopade OI, Foulkes WD, Karlan B, Warner E, Rosen B, Rebbeck T, Tonin P, Dubé M-P, Kieback DG, Narod S. Progesterone receptor variant increases ovarian cancer risk in BRCA1 and BRCA2 mutation carriers who were never exposed to oral contraceptives. Pharmacogenetics 2001; 11: 635-638.
31. Tong D, Fabjani G, Heinze G, Obermair A, Leodolter S, Zeillinger R. Analysis of the human progesterone receptor gene polymorphism PROGINS in Austrian ovarian carcinoma patients. Int J Can (Pred Oncol) 2001; 95: 394-397.
32. Rebbeck TR, Wang Y, Kantoff PW, Krithivas K, Neuhausen SL, Godwin AK, Daly MB, Narod SA, Brunet J-S, Vesprini D, Garber JE, Lynch HT, Weber BL, Brown M. Modification of BRCA1-and BRCA2-associated breast cancer risk by AIB1 genotype and reproductive history. Cancer Res 2001; 61: 5420-5424.
33. Hsing AW, Chokkalingam AP, Gao Y-T, Wu G, Wang X, Deng J, Cheng J, Sesterhenn IA, Mostofi FK, Chiang T, Chen Y-L, Stanczyk FZ, Chang C. Polymorphic CAG/CAA repeat length in the AIB1/SRC-3 gene and prostate cancer risk: a population-based case-control study. Cancer Epidemiol Biomarkers Prev 2002; 11: 317-341.
34. Soules MR, Sherman S, Parrott E, Rebar R, Santoro N, Utian W, Woods N. Executive summary: stages of reproductive aging workshop (STRAW). Fertility Sterility 2001; 76: 874-878.
35. Pierce JP, Faerber S, Wright F, Rock C, Newman V, Flatt S, Kealy S, Jones V, Caan B, Gold E, Haan M, Hollenbach K, Jones L, Marshall J, Ritenbaugh C, Stefanick M, Thomson C, Wasserman L, Natarajan L, Gilpin B. A randomized trial of the effect of a plant-based dietary pattern on additional breast cancer events and survival: The Women's Healthy Eating and Living (WHEL) Study. Controlled Clin Trials 2002; 23: 728-756.
36. Power C, Lake JK, Cole TJ. Body mass index and height from childhood to adulthood in the 1958 British born cohort. Am J Clin Nutr 1997; 66: 1094-1101.
37. Williams S, Dickson N. Early growth, menarche and adiposity rebound. Lancet 2002; 359: 580-581.
38. Grabrick DM, Vierkant RA, Anderson KE, Cerhan JR, Anderson VE, Sellers TA. Association of correlates of endogenous hormonal exposure with breast cancer risk in 426 families (United States). Cancer Causes Control 2002; 13: 333-341.
39. Clavel-Chapelon F, Gerber M. Reproductive factors and breast cancer risk. Do they differ according to age at diagnosis. Br Cancer Res Treat 2002; 72: 107-115.
40. Lahti-Koski M, Pietinen P, Heliövaara M, Vartiainen E. Associations of body mass index and obesity with physical activity, food choices, alcohol intake and smoking in the 1982-1997 FINRISK studies. Am J Clin Nutr 2002; 75: 809-817.
41. Seidell JC. Dietary fat and obesity: an epidemiologic perspective. Am J Clin Nutr 1998; 67 (Suppl): 546S-550S.
42. Willett W. Is dietary fat a major determinant of body fat? Am J Clin Nutr 1998; 67 (Suppl): 556S-562S.
43. Klesges RC, Klesges LM, Haddock CK, Eck LH. A longitudinal analysis of the impact of dietary intake and physical activity on weight change in adults. Am J Clin Nutr 1992; 55: 818-822.